Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Vivos Therapeutics Inc

VVOS ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: BUY

Last Close

$0.34

▲ +12.45%

Market Cap $4.77M · Vol 104.09K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$4.77M

Micro Cap

Div Yield

N/A

EPS Growth

+34.46%

YoY

RSI (14)

40.81

Momentum

Beta

5.98

vs Market

52W High

$5.11

93.28% below

52W Low

$0.27

26.12% above

Volume

104.09K

Avg 152.73K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

73.65%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Vivos Therapeutics Inc (VVOS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does VVOS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.96%

-16.21%

-50.25%

-77.41%

YTD

-83.09%

-92.55%

-95.79%

-99.58%

Financials & Valuation

TTM · Annual

Total Revenue	$17.44M
Net Income	$-21,230,000.00
Revenue Growth (YoY)	+34.90%
Gross Margin	52.93%
Operating Margin	-114.05%
Net Profit Margin	-121.71%
ROE	N/A
ROA · ROIC	-105.01% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.20
P/B	N/A
P/FCF	N/A
EPS Growth	+34.46%
Outstanding Shares	13.89M

Technical Indicators

50-Day SMA	$0.46
200-Day SMA	$1.30
RSI (14)	40.81
Beta	5.98
52-Week High	$5.11
52-Week Low	$0.27

Volume Today	104.09K
Avg Daily Volume (30D)	152.73K
Relative Volume	0.68x
Volatility (10D)	180.69
Volatility (30D)	111.35
Free Float	73.65%

Analyst Consensus

BUY

Current Price $0.34

Mean Target $2.12

52W Low$0.27 52W High$5.11

Current

Target

$0.27 $5.11

Current Analyst target

+516.57% upside potential · 3 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00H1NZV85

ISINUS92859E2072

CountryUnited States of America

Sub-IndustryMedical Equipment

Earnings DateAug 17, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

PEN Penumbra Inc +0.08% GETI B.ST Getinge publ AB +0.08% 7747.T Asahi Intecc Co Ltd -0.97% MMED MiniMed Group Inc +0.65% 688617.SS APT Medical Inc +0.14%

Company Profile

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.